8-K
filed June 3, 2026, 4:15 PM ET
ticker AMPH
CIK 0001297184
other
confidence high
sentiment neutral
materiality 0.15
Amphastar shareholders elect three directors, ratify EY, approve say-on-pay
Amphastar Pharmaceuticals, Inc.
- All three Class I nominees elected: Gaugh 35.2M for, Peters 23.6M for, Liawatidewi 23.2M for.
- Peters and Liawatidewi each received over 11.7M against votes.
- Ratification of Ernst & Young as auditor for FY2026 passed 39.2M to 0.7M.
- Advisory say-on-pay approved 32.6M for; frequency set at 1 year with 33.8M votes.
- All proposals passed with broker non-votes of 4.4M on director and advisory items.
Key facts
Extracted from this filing and checked against the source text.
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
Amphastar Pharmaceuticals, Inc. shareholders approved Advisory vote on compensation of named executive officers.
- Proposal
- say on pay
- Outcome
- passed
Exact text from the filing
3. Advisory Vote on the Compensation of our Named Executive Officers For Against Abstained Broker Non-votes 32,585,908 2,779,281 111,803 4,439,978
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
Amphastar Pharmaceuticals, Inc. shareholders approved Advisory vote on frequency of future stockholder advisory votes on named executive officer compensation.
- Proposal
- say on pay frequency
- Outcome
- passed
Exact text from the filing
4. Advisory Vote on the Frequency of Future Stockholder Advisory Votes on Named Executive Officer Compensation 1 Year 2 Years 3 Years Abstained Broker Non-votes 33,816,071 12,329 1,624,016 24,576 4,439,978
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
Amphastar Pharmaceuticals, Inc. shareholders approved Election of three Class I directors.
- Proposal
- director election
- Outcome
- passed
Exact text from the filing
1. Election of Directors Nominee For Against Abstained Broker Non-votes David Gaugh 35,242,863 209,084 25,045 4,439,978 William J. Peters 23,652,131 11,785,772 39,089 4,439,978 Jacob Liawatidewi 23,224,791 12,212,988 39,213 4,439,978
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
Amphastar Pharmaceuticals, Inc. shareholders approved Ratification of Ernst & Young LLP as independent registered public accounting firm.
- Proposal
- auditor ratification
- Outcome
- passed
Exact text from the filing
2. Ratification of Appointment of Independent Registered Public Accounting Firm For Against Abstained Broker Non-votes 39,179,786 684,828 52,356 N/A
View on SEC.gov
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.